{
    "nctId": "NCT00639106",
    "briefTitle": "Tissue Expander/Implant Reconstruction: A Single-Blinded, Randomized, Controlled Trial",
    "officialTitle": "The Use of Alloderm in Two-Stage, Tissue Expander/Implant Reconstruction: A Single-Blinded, Randomized, Controlled Trial",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 70,
    "primaryOutcomeMeasure": "whether using Alloderm to create the inferior-medial portion of the expander pocket will decrease patient-reported pain in both the immediate, post-operative period and during the expansion phase.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients who undergo immediate, postmastectomy, tissue expander/implant reconstruction\n* Patients \u2265 21 and \u2264 75 years of age\n\nExclusion Criteria:\n\n* Patient refusal\n* Patients who will undergo any of the following:\n* Single-stage implant reconstruction\n* Combined autogenous tissue expander/implant reconstruction\n* Patients with a history of prior irradiation\n* Patients with a history of prior surgery with breast implants\n* Patients with a history of prior axillary lymph node dissection\n* Patients who are pregnant\n\nThe following eligibility will be confirmed at the time of surgery.\n\n* Patients who are deemed intraoperatively by the attending surgeon to have significant mastectomy flap ischemia.\n* Patients who have an axillary lymph node dissection at the time of mastectomy (Patients undergoing sentinel lymph biopsy are eligible)",
    "sex": "FEMALE",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}